IRCT20200608047686N2
Recruiting
Phase 2
Comparison of therapeutic effects of hemoperfusion in intubated and non-intubated patients with respiratory failure caused by the COVID-19
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- COVID-19.
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Hospitalized patients with respiratory failure caused by the COVID\-19
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Hemoperfusion effect in treatment of patients with COVID-19IRCT20110425006280N12Vice President of Research Guilan university of medical sciences20
Recruiting
Phase 2
Hemoperfusion in Covid 19IRCT20210718051922N1Shahre-kord University of Medical Sciences60
Recruiting
Not Applicable
Efficacy of the Hemoperfusion Therapy in Patients with Severe COVID-19-Associated Pneumonia: An Experience from Single-center Observational StudySevere COVID-19-associated pneumonia with or without hemoperfusion therapyHemoperfusion, adsorption therapy, COVID-19, Pneumonia, Acute respiratory distress syndrome, Critical care, SARS-CoV2, cytokine storm, blood purificationTCTR20210627002Faculty of Medicine, Chiang Mai University15
Completed
Phase 2
Hemoperfusion in patients with COVID-19IRCT20150704023055N2Babol University of Medical Sciences10
Completed
Not Applicable
Clinical research for hemoperfusion therapy with an immobilized polymyxin B (PMX) fiber column in patients with severe influenza pneumonia in Vietnam and Japasevere influenza pneumoniaJPRN-UMIN000003669Disease Control and Prevention Center10